↓ Skip to main content

A Pragmatic Non-Randomized Trial of Prehabilitation Prior to Cancer Surgery: Study Protocol and COVID-19-Related Adaptations

Overview of attention for article published in Frontiers in oncology, March 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter
2 X users

Readers on

mendeley
206 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A Pragmatic Non-Randomized Trial of Prehabilitation Prior to Cancer Surgery: Study Protocol and COVID-19-Related Adaptations
Published in
Frontiers in oncology, March 2021
DOI 10.3389/fonc.2021.629207
Pubmed ID
Authors

Daniel Santa Mina, Daniel Sellers, Darren Au, Shabbir M. H. Alibhai, Hance Clarke, Brian H. Cuthbertson, Gail Darling, Alaa El Danab, Anand Govindarajan, Karim Ladha, Andrew G. Matthew, Stuart McCluskey, Karen A. Ng, Fayez Quereshy, Keyvan Karkouti, Ian M. Randall

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 206 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 206 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 19 9%
Student > Master 16 8%
Student > Ph. D. Student 14 7%
Student > Doctoral Student 14 7%
Researcher 12 6%
Other 42 20%
Unknown 89 43%
Readers by discipline Count As %
Medicine and Dentistry 49 24%
Nursing and Health Professions 18 9%
Unspecified 10 5%
Sports and Recreations 7 3%
Psychology 7 3%
Other 20 10%
Unknown 95 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 December 2021.
All research outputs
#16,734,944
of 25,387,668 outputs
Outputs from Frontiers in oncology
#6,619
of 22,433 outputs
Outputs of similar age
#268,996
of 452,055 outputs
Outputs of similar age from Frontiers in oncology
#337
of 998 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,433 research outputs from this source. They receive a mean Attention Score of 3.0. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 452,055 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 998 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.